FightSMA - Accelerating a cure for spinal muscular atrophy Fight Spinal Muscular Atrophy - HomeContact Fight SMA Spinal Muscular Atrophy - Home

Spinal Muscular Atrophy Research News

Samuel at the 2007 FightSMA Annual Conference
(2007)

Jump to

SMA Research News

August 23, 2010 SMA to be represented at the 2010 SfN meeting
August 19, 2010 More studies show concern about cardiac defects in SMA patients
August 12, 2010 October Course for Medical Professionals on Recent Advances in SMA and Other Pediatric Neuromuscular Diseases
August 4, 2010 October Workshop for Investigators on Conducting Research on Rare Diseases and Orphan Products
July 12, 2010 CSHL researchers demonstrate efficacy of antisense therapy for spinal muscular atrophy
June 23, 2010 SMA mechanisms and therapeutic strategies
May 20, 2010 Beyond STOP SMA: the path forward
May 19, 2010 FightSMA Awards $250,000 Grant to Gene Researcher at The Ohio State University
May 18, 2010 Investigating the Impact of Nutrition on SMA
May 6, 2010 Advances in stem cell delivery: Implications for ALS and SMA
May 5, 2010 NIH Starts to Flesh Out Drug Development Program
March 29, 2010 Genetic therapy for spinal muscular atrophy
March 25, 2010 SMA Foundation announces the discovery of over 400 candidate biomarkers from the BforSMA study
March 24, 2010 RFI: Program to Advance Development of Drug Candidates for Rare and Neglected Diseases
March 15, 2010 Study opens new avenue for developing treatments for genetic muscle-wasting disease
March 9, 2010 A New Finding Clarifies the Cause of Spinal Muscular Atrophy
February 4, 2010 NIH Releases FY09 Estimates of Funding for Various Diseases, Conditions, and Research Areas
January 2010 Ensuring Successful Submission of Newly Restructured Applications (NIH)
January 2010 NINDS Funding Strategy - FY10

Funding Opportunities and RFIs

Deadline:
September 13, 2010		 2011 NIH Director's Pioneer Award Program (DP1)
Deadline:
October 21, 2010		 Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) (R01)
Note, that over the last three years the EUREKA mechanism has had a success rate much more in line with standard R01 applications. Each of these offers an opportunity not as easily addressed in regular NIH funding mechanisms.
Deadline:
October 27, 2010		 NIH Common Fund Transformative Research Projects Program (R01)
Deadline:
November 17, 2010		 Scalable Assays for Unbiased Analysis of Neurobiological Function (R01)
Deadline:
February 4, 2011		 FightSMA Research Grant Application
Deadline:
Standard dates apply 		Exploratory/Developmental Projects in Translational Research for Neuromuscular Disease (R21) - PAR-08-228
Deadline:
Standard dates apply 		Cooperative Program in Translational Research for Neuromuscular Disease (U01) - PAR-08-229
Deadline:
Standard dates apply		 NINDS Cooperative Program in Translational Research Multi-Component Research Projects (U54) - PAR-08-234
Deadline:
Standard dates apply		 NINDS Cooperative Program in Translational Research Small Business Awards (SBIR [U44]) - PAR-08-235
Deadline:
Standard dates apply		 NINDS Cooperative Program in Translational Research Resource Centers (U24) - PAR-08-236
 

Home | About FightSMA | What is SMA? | Research News | Chapters | Events | Merchandise | Press | Legislative Info | Donate
Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III | Spinal Muscular Atrophy Type IV
Spinal Muscular Atrophy Tests | Spinal Muscular Atrophy Treatment | Spinal Muscular Atrophy Doctors | Spinal Muscular Atrophy Blog